Adheres easily to wounds including those with irregular surfaces*
Dehydrated extracellular matrix acts as a scaffold supporting the native tissue
*NeoStim TL is an amniotic membrane allograft derived from a prescreened mother with a planned C-section delivery. NeoStim TL is manufactured in compliance with FDA regulations. The membrane is minimally processed to preserve the native structure of the tissue, dehydrated, and terminally sterilized. NeoStim TL is confirmed by the FDA Tissue Reference Group to meet the criteria for regulation solely under Section 361 of the PHS Act as defined in 21 CFR Part 1271.
